InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

GLUE Clue Score47
United States Fiscal year ends December CIK 0001826457 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

37
Insider
Date
Role
Action
Shares
Price
Amount
Matthew Bowen
5 Oct 2026
Principal Accounting Officer
Sell
13
$10.56
$137.28
Markus Warmuth
16 Jul 2026
President & CEO
Sell
9,500
$23.18
$220.22K
Jennifer Champoux
15 Jul 2026
Chief Operating Officer
Sold after exercise
4,351
$23.38
$101.73K
Sharon Townson
6 Jul 2026
Chief Scientific Officer
Sold after exercise
400
$24.13
$9.65K
Sharon Townson
6 Jul 2026
Chief Scientific Officer
Sold after exercise
5,600
$23.25
$130.20K
Filip Janku
30 Jun 2026
Chief Medical Officer
Sold after exercise
5,407
$24.50
$132.47K
Anthony M. Manning
29 Jun 2026
Director
Sold after exercise
10,000
$23.11
$231.10K
Filip Janku
29 Jun 2026
Chief Medical Officer
Sold after exercise
6,000
$22.95
$137.70K
Filip Janku
24 Jun 2026
Chief Medical Officer
Sold after exercise
30,000
$21.42
$642.68K
Sharon Townson
23 Jun 2026
Chief Scientific Officer
Sold after exercise
3,000
$20.00
$60.00K
Jennifer Champoux
23 Jun 2026
Chief Operating Officer
Sold after exercise
2,175
$20.00
$43.50K
Filip Janku
23 Jun 2026
Chief Medical Officer
Sold after exercise
11,845
$20.22
$239.52K
Sharon Townson
17 Jun 2026
Chief Scientific Officer
Sold after exercise
3,000
$19.00
$57.00K
Jennifer Champoux
17 Jun 2026
Chief Operating Officer
Sold after exercise
2,176
$19.00
$41.34K
Markus Warmuth
1 Jun 2026
President & CEO
Sold on a plan
468
$19.73
$9.23K
Markus Warmuth
1 Jun 2026
President & CEO
Sold on a plan
4,998
$19.41
$97.02K
Sharon Townson
29 May 2026
Chief Scientific Officer
Sold after exercise
6,000
$19.87
$119.22K
Jennifer Champoux
27 May 2026
Chief Operating Officer
Sold after exercise
2,175
$20.00
$43.50K
Jennifer Champoux
22 May 2026
Chief Operating Officer
Sold after exercise
2,176
$19.00
$41.34K
Anthony M. Manning
21 May 2026
Director
Sold after exercise
10,000
$18.01
$180.10K
Markus Warmuth
1 May 2026
President & CEO
Sold on a plan
5,467
$18.92
$103.45K
Markus Warmuth
14 Apr 2026
President & CEO
Sell
8,000
$17.64
$141.12K
Philip Nickson
9 Apr 2026
Chief Business & Legal Officer
Sell
5,845
$17.69
$103.41K
Edmund Dunn
4 Mar 2026
Principal Accounting Officer
Sell
139
$17.96
$2.50K
Edmund Dunn
2 Mar 2026
Principal Accounting Officer
Sold after exercise
536
$17.50
$9.38K
Markus Warmuth
2 Mar 2026
President & CEO
Sold on a plan
5,466
$17.92
$97.97K
Edmund Dunn
27 Feb 2026
Principal Accounting Officer
Sold after exercise
25,164
$18.10
$455.51K
Filip Janku
23 Feb 2026
Chief Medical Officer
Sell
9,189
$19.50
$179.16K
Markus Warmuth
7 Jan 2026
President & CEO
Sold on a plan
309
$24.57
$7.59K
Markus Warmuth
7 Jan 2026
President & CEO
Sold on a plan
1,450
$23.88
$34.62K
Markus Warmuth
7 Jan 2026
President & CEO
Sold on a plan
3,707
$23.24
$86.16K
Sharon Townson
5 Jan 2026
Chief Scientific Officer
Sell
3,155
$15.17
$47.86K
Filip Janku
5 Jan 2026
Chief Medical Officer
Sell
3,155
$15.17
$47.86K
Markus Warmuth
5 Jan 2026
President & CEO
Sell
10,135
$15.17
$153.75K
Edmund Dunn
5 Jan 2026
Principal Accounting Officer
Sell
1,039
$15.17
$15.76K
Jennifer Champoux
5 Jan 2026
Chief Operating Officer
Sell
2,629
$15.17
$39.88K
Philip Nickson
5 Jan 2026
Chief Business & Legal Officer
Sell
3,155
$15.17
$47.86K

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 18
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 1,377,460
History held since 25 Jun 2021